Subtype-selective Nav1.8 sodium channel blockers: Identification of potent, orally active nicotinamide derivatives
Authors:
- 1 November 2010
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (22) , 6812-6815
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Voltage-gated sodium channels in pain states: Role in pathophysiology and targets for treatmentBrain Research Reviews, 2009
- A Selective Nav1.8 Sodium Channel Blocker, A-803467 [5-(4-Chlorophenyl-N-(3,5-dimethoxyphenyl)furan-2-carboxamide], Attenuates Spinal Neuronal Activity in Neuropathic RatsThe Journal of Pharmacology and Experimental Therapeutics, 2008
- A-803467, a potent and selective Na v 1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the ratProceedings of the National Academy of Sciences, 2007
- Cross‐Coupling Reactions on Azoles with Two and More HeteroatomsEuropean Journal of Organic Chemistry, 2006
- International Union of Pharmacology. XLVII. Nomenclature and Structure-Function Relationships of Voltage-Gated Sodium ChannelsPharmacological Reviews, 2005
- Palladium-Catalyzed Cross-Coupling Reactions in Total SynthesisAngewandte Chemie International Edition, 2005
- Voltage-Gated Sodium Channels and HyperalgesiaAnnual Review of Pharmacology and Toxicology, 2004
- From Ionic Currents to Molecular MechanismsNeuron, 2000
- Discovery, Synthesis, and Bioactivity of Bis(heteroaryl)piperazines. 1. A Novel Class of Non-Nucleoside HIV-1 Reverse Transcriptase InhibitorsJournal of Medicinal Chemistry, 1994
- An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the ratPain, 1992